Novo Nordisk (NVO 2.98%) stock investors are eagerly awaiting the potential launch of its weight loss treatment in oral form.
*Stock prices used were the afternoon prices of Sept. 25, 2025. The video was published on Sept. 27, 2025.
Why Is Novo Nordisk Stock Down in 2025, and Is It a Buying Opportunity?
By Parkev Tatevosian, CFA – Sep 30, 2025 at 6:30AM
NYSE: NVO
Novo Nordisk
Market Cap
$184B
Today's Change
(-2.98%) $1.64
Current Price
$53.15
Price as of October 22, 2025 at 2:56 PM ET
Political pressure on Big Pharma is one reason why the industry is underperforming in 2025.
About the Author
A Fool since 2019, and a graduate of Cal State LA with a B.S. in Finance and M.A. in Economics. Parkev is an adjunct professor of Finance and enjoys reading about financial and economic history. You'll often find him writing about stocks in the consumer goods and technology sectors.